Wenwen Ge

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Rapidly gelling platelet-rich plasma-loaded carboxymethyl hydroxybutyl chitosan hydrogel for colonic repair and adhesion reduction.

Rapidly gelling platelet-rich plasma-loaded carboxymethyl hydroxybutyl chitosan hydrogel for colonic repair and adhesion reduction.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 22, 2026

Hepatocyte-like cell therapy for end-stage liver disease: From basic science to clinical application.

Hepatocyte-like cell therapy for end-stage liver disease: From basic science to clinical application.

Journal: Liver research (Beijing, China)

Published: November 27, 2024

Natural killer cell-derived granzyme B as a therapeutic target for alleviating graft injury during liver transplantation.

Natural killer cell-derived granzyme B as a therapeutic target for alleviating graft injury during liver transplantation.

Journal: Acta pharmaceutica Sinica. B

Published: September 16, 2024

Human amniotic epithelial stem cells promote cholangiocyte regeneration via Notch signaling pathway in bile duct injury.

Human amniotic epithelial stem cells promote cholangiocyte regeneration via Notch signaling pathway in bile duct injury.

Journal: Chinese medical journal

Published: September 09, 2024

PLK2 inhibited oxidative stress and ameliorated hepatic ischemia-reperfusion injury through phosphorylating GSK3β.

PLK2 inhibited oxidative stress and ameliorated hepatic ischemia-reperfusion injury through phosphorylating GSK3β.

Journal: Journal of gastroenterology and hepatology

Published: August 23, 2024

Potential crosstalk between Naïve CD4+ T cells and SPP1+ Macrophages is associated with clinical outcome and therapeutic response in hepatocellular carcinoma.

Potential crosstalk between Naïve CD4+ T cells and SPP1+ Macrophages is associated with clinical outcome and therapeutic response in hepatocellular carcinoma.

Journal: International immunopharmacology

Published: July 05, 2024

Inhibition of cysteine-serine-rich nuclear protein 1 ameliorates ischemia-reperfusion injury during liver transplantation in an MAPK-dependent manner.

Inhibition of cysteine-serine-rich nuclear protein 1 ameliorates ischemia-reperfusion injury during liver transplantation in an MAPK-dependent manner.

Journal: Molecular biomedicine

Published: February 23, 2024

PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer.

PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 21, 2023

Incorporation of protein induced by vitamin K absence or antagonist-II into transplant criteria expands beneficiaries of liver transplantation for hepatocellular carcinoma: a multicenter retrospective cohort study in China.

Incorporation of protein induced by vitamin K absence or antagonist-II into transplant criteria expands beneficiaries of liver transplantation for hepatocellular carcinoma: a multicenter retrospective cohort study in China.

Journal: International journal of surgery (London, England)

Published: June 19, 2023

Showing 1-9 of 9

Last Updated: 09/26/2026